FOLH1 and neoplasm: [177Lu]Lu-PSMA-ALB-56 applied at the same activity showed an even slightly increased tumor growth delay (TGDI2 of 1.9 ± 0.6 and TGDI5 of 1.7 ± 0.5, respectively).